Literature DB >> 2315508

Flexible tantalum stents implanted in aortas and iliac arteries: effects in normal canines.

K H Barth1, R Virmani, E P Strecker, M A Savin, D Lindisch, A H Matsumoto, G P Teitelbaum.   

Abstract

Vascular endoprostheses made of knitted tantalum wire and expanded over angioplasty balloons were placed into aortas or iliac arteries of 14 normal dogs. Twelve stents were placed into the infrarenal abdominal aorta and two stents in the left common iliac arteries by the left carotid artery approach. To firmly expand the stent against the vascular wall, nominal stent sizes 0.5-1.0 mm larger than the measured arterial diameter were required. Arteriography performed at specified follow-up intervals showed no evidence of thrombi or emboli; all side branches (lumbar arteries) covered by the stents remained patent. Vascular diameter decreased minimally at 8 and 26 weeks, associated with histopathologic evidence of neointimal buildup. This buildup was highest at 8 weeks (mean, 313 microns) and was slightly less at 26 weeks (mean, 223 microns). Almost complete coverage by endothelium was seen as early as 3 weeks. It is concluded that the flexible tantalum wire stents are well tolerated by the arterial wall and become quickly endothelialized. No excessive neointimal buildup was observed during the 6-month study.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315508     DOI: 10.1148/radiology.175.1.2315508

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

1.  The Strecker stent: indications and results in iliac and femoropopliteal arteries.

Authors:  D Liermann; E P Strecker; J Peters
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

2.  Percutaneous reconstruction of the aortic bifurcation with Palmaz stents: case report.

Authors:  G Küffer; F Spengel; B Steckmeier
Journal:  Cardiovasc Intervent Radiol       Date:  1991 May-Jun       Impact factor: 2.740

3.  Application of intraluminal ultrasound imaging to vascular stenting.

Authors:  M J Slepian
Journal:  Int J Card Imaging       Date:  1991

4.  Intravascular stents: a new technique for tissue processing for histology, immunohistochemistry, and transmission electron microscopy.

Authors:  N Malik; J Gunn; C M Holt; L Shepherd; S E Francis; C M Newman; D C Crossman; D C Cumberland
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

Review 5.  Endovascular techniques in limb salvage: stents.

Authors:  Hosam F El-Sayed
Journal:  Methodist Debakey Cardiovasc J       Date:  2013-04

6.  Neointima formation following arterial placement of self-expanding stents of different radial force: experimental results.

Authors:  D Vorwerk; F Redha; J Neuerburg; C Clerc; R W Günther
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Jan-Feb       Impact factor: 2.740

7.  Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries.

Authors:  D Liermann; H D Bottcher; J Kollath; B Schopohl; G Strassmann; E P Strecker; K H Breddin
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Jan-Feb       Impact factor: 2.740

8.  Plasma treatment effects on the tantalum Strecker stent implanted in femoral arteries of sheep.

Authors:  D Crochet; R Grossetête; B Bach-Lijour; C Sagan; E Lecomte; B Leurent; P Brunel; J C Le Nihouannen
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Sep-Oct       Impact factor: 2.740

9.  Deposition of platelets and neutrophils in porcine iliac arteries after angioplasty and Wallstent placement compared with angioplasty alone.

Authors:  H Pärsson; W Cwikiel; K Johansson; P Swartbol; L Norgren
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Jul-Aug       Impact factor: 2.740

10.  Suitability of incorporated vascular stents for surgical patch-plasty: an experimental study.

Authors:  K Schürmann; D Vorwerk; C Rosenbaum; K Eckert; S Biesterfeld; T Stopinski; R W Günther
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jul-Aug       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.